Cubist Systematic Strategies, LLC Y M Abs Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.25 $825,792 - $1.23 Million	-71,189 Reduced 91.52%	6,597 $79,000
Q1 2024 May 15, 2024	BUY	$6.57 - $18.69 $267,228 - $760,197	40,674 Added 109.6%	77,786 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$4.88 - $7.42 $2,727 - $4,147	559 Added 1.53%	37,112 $253,000
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $495,695 - $737,423	-101,995 Reduced 73.62%	36,553 $199,000
Q2 2023 Aug 14, 2023	BUY	$5.68 - $10.34 $463,050 - $842,947	81,523 Added 142.96%	138,548 $940,000
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $50,560 - $91,295	17,866 Added 45.62%	57,025 $285,000
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $87,477 - $442,342	29,159 Added 291.59%	39,159 $191,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $7,566 - $10,661	-542 Reduced 5.14%	10,000 $144,000
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $18,421 - $33,906	-2,241 Reduced 17.53%	10,542 $160,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $83,728 - $222,679	12,783 New	12,783 $152,000
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $230,850 - $436,250	-14,884 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $408,863 - $555,322	14,884 New	14,884 $425,000
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $156,180 - $278,297	-5,356 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $202,778 - $290,616	5,356 New	5,356 $265,000
Q3 2019 Nov 14, 2019	SELL	$21.57 - $31.37 $11,216 - $16,312	-520 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $10,145 - $14,721	520 New	520 $12,000
Q4 2018 Feb 14, 2019	SELL	$15.41 - $28.92 $32,083 - $60,211	-2,082 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$24.0 - $26.97 $49,968 - $56,151	2,082 New	2,082 $55,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$45.5 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$32.7 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$24.4 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$22.7 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$20.4 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account